HighTower Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.4K Buy
35,322
+3,103
+10% +$3.78K ﹤0.01% 3720
2025
Q4
$31.7K Sell
32,219
-4,981
-13% -$5.98K ﹤0.01% 3595
2025
Q3
$46.9K Hold
37,200
﹤0.01% 3616
2025
Q2
$41.7K Buy
37,200
+27,000
+265% +$31.4K ﹤0.01% 3563
2025
Q1
$8.06K Hold
10,200
﹤0.01% 3565
2024
Q4
$16.8K Sell
10,200
-400
-4% -$1.01K ﹤0.01% 3556
2024
Q3
$37K Sell
10,600
-604
-5% -$2.35K ﹤0.01% 3444
2024
Q2
$37K Buy
11,204
+104
+0.9% +$455 ﹤0.01% 3337
2024
Q1
$81K Buy
11,100
+200
+2% +$1.24K ﹤0.01% 3192
2023
Q4
$40K Sell
10,900
-5,071
-32% -$12K ﹤0.01% 3333
2023
Q3
$33K Sell
15,971
-200
-1% -$663 ﹤0.01% 3273
2023
Q2
$78K Sell
16,171
-485
-3% -$2.68K ﹤0.01% 3117
2023
Q1
$94K Buy
16,656
+881
+6% +$5.32K ﹤0.01% 2961
2022
Q4
$159K Sell
15,775
-1,694
-10% -$31.8K ﹤0.01% 2839
2022
Q3
$391K Buy
17,469
+7,019
+67% +$203K ﹤0.01% 2187
2022
Q2
$261K Sell
10,450
-7,911
-43% -$218K ﹤0.01% 2451
2022
Q1
$714K Buy
18,361
+1,016
+6% +$39.3K ﹤0.01% 1956
2021
Q4
$1.02M Buy
17,345
+4,182
+32% +$237K ﹤0.01% 1754
2021
Q3
$779K Sell
13,163
-487
-4% -$38.2K ﹤0.01% 1795
2021
Q2
$1.19M Buy
13,650
+7,098
+108% +$572K ﹤0.01% 1535
2021
Q1
$540K Buy
+6,552
New +$628K ﹤0.01% 1926

Other funds holding FATE